Cargando…
Pioglitazone ameliorates Aβ42 deposition in rats with diet-induced insulin resistance associated with AKT/GSK3β activation
Pioglitazone may have potential benefits as an alternative therapeutic treatment for patients with Alzheimer's disease (AD), particularly in individuals that also have comorbid diabetes; however, the mechanisms of action remain unclear. The present study aimed to explore the effects of pioglita...
Autores principales: | Yang, Sisi, Chen, Zhe, Cao, Ming, Li, Renjie, Wang, Zhigang, Zhang, Muxun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428924/ https://www.ncbi.nlm.nih.gov/pubmed/28447730 http://dx.doi.org/10.3892/mmr.2017.6342 |
Ejemplares similares
-
Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways
por: Wei, Wen-Ying, et al.
Publicado: (2016) -
Urocortin ameliorates diabetic cardiomyopathy in rats via the Akt/GSK-3β signaling pathway
por: LIU, XINYU, et al.
Publicado: (2015) -
AKT/GSK3β Signaling in Glioblastoma
por: Majewska, Ewelina, et al.
Publicado: (2016) -
Cryptotanshinone Ameliorates Doxorubicin-Induced Cardiotoxicity by Targeting Akt-GSK-3β-mPTP Pathway In Vitro
por: Wang, Xiaoping, et al.
Publicado: (2021) -
GSK3β Inhibition Ameliorates Atherosclerotic Calcification
por: Cai, Xinjiang, et al.
Publicado: (2023)